
Nektar Therapeutics NKTR
€ 49.00
-1.36%
Geschäftsbericht 2023
hinzugefügt 05.03.2024
Nektar Therapeutics P/S 2011-2025 | NKTR
P/S Jährlich Nektar Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.86 | 2.83 | 20 | 23 | 31 | 6.13 | 41.8 | 9.91 | 7.83 | 9.25 | 10.9 | 12 | 10.1 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 41.8 | 1.86 | 14.4 |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
29.8 | $ 3.56 | -2.47 % | $ 1.05 B | ||
|
AC Immune SA
ACIU
|
35 | $ 2.81 | -2.43 % | $ 229 M | ||
|
ADiTx Therapeutics
ADTX
|
0.442 | $ 2.99 | 2.75 % | $ 39.4 K | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
Abeona Therapeutics
ABEO
|
42.7 | $ 4.81 | -1.33 % | $ 103 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Amneal Pharmaceuticals
AMRX
|
0.654 | $ 11.96 | 0.17 % | $ 3.7 B | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
argenx SE
ARGX
|
311 | $ 898.63 | -1.89 % | $ 25 B | ||
|
Armata Pharmaceuticals
ARMP
|
110 | $ 5.91 | 1.55 % | $ 213 M | ||
|
Achieve Life Sciences
ACHV
|
3.19 | $ 4.68 | -2.2 % | $ 92.8 M | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 205.89 | -1.29 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.48 | 1.45 % | $ 8.37 B | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Baudax Bio
BXRX
|
0.614 | - | 0.59 % | $ 63 K | ||
|
AbbVie
ABBV
|
22.7 | $ 225.34 | -1.46 % | $ 399 B | ||
|
Cara Therapeutics
CARA
|
2.58 | - | -3.03 % | $ 260 M | ||
|
CymaBay Therapeutics
CBAY
|
110 | - | - | $ 3.45 B | ||
|
ChemoCentryx
CCXI
|
0.0564 | - | - | $ 3.74 B | ||
|
Codiak BioSciences
CDAK
|
10.5 | - | -55.98 % | $ 2.15 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
6.58 | $ 15.35 | -12.11 % | $ 2.26 B | ||
|
Avid Bioservices
CDMO
|
3.03 | - | - | $ 789 M | ||
|
Biogen
BIIB
|
2 | $ 182.33 | 0.19 % | $ 26.5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Beam Therapeutics
BEAM
|
39.4 | $ 27.55 | -4.72 % | $ 2.27 B | ||
|
BioMarin Pharmaceutical
BMRN
|
4.6 | $ 53.06 | -1.41 % | $ 10.1 B | ||
|
BioNTech SE
BNTX
|
35.7 | $ 96.0 | - | $ 27.2 B | ||
|
Clearside Biomedical
CLSD
|
12.3 | - | - | $ 25.3 M | ||
|
Celsion Corporation
CLSN
|
26.1 | - | -6.63 % | $ 13.9 M | ||
|
Clovis Oncology
CLVS
|
1.55 | - | -7.23 % | $ 13 M | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Chimerix
CMRX
|
320 | - | - | $ 756 M | ||
|
Concert Pharmaceuticals
CNCE
|
41.3 | - | - | $ 401 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 | $ 9.36 | -2.65 % | $ 605 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K |